Search Menu
Photonics Media Photonics Buyers' Guide Photonics EDU Photonics Spectra BioPhotonics EuroPhotonics Industrial Photonics Photonics Showcase Photonics ProdSpec Photonics Handbook
More News
Email Facebook Twitter Google+ LinkedIn Comments

FDA Clears Light-Based Acne Treatment
Aug 2002
SANTA CLARA, Calif., August 21 -- Lumenis Ltd. has received clearance from the Food and Drug Administration (FDA) to market its acne treatment device, The ClearLight system, for certain types of acne. The system uses high-intensity, narrow-band phototherapeutic light to destroy acne-causing bacteria.

A.R. Shalita, M.D., of SUNY Downstate Medical Center in Brooklyn, N.Y., led the ClearLight clinical trials. "ClearLight is an important new treatment for acne. It's effective, painless and, most importantly, has no known side effects," he said.

The treatment destroys Propionibacterium acnes bacteria, or P. acnes, the primary cause of most acne. The device's high-intensity light excites the porphyrins, resulting in photodestruction of the acne bacteria without damaging the surrounding tissue or skin.

The typical ClearLight treatment regimen consists of eight visits over a period of four weeks. While any area of the body that has moderate inflammatory acne can be treated, the most common areas are the face, neck, chest and back. The ClearLight system works equally well on patients of all skin colors, Lumenis said.

ClearLight was launched in Canada, Europe and Japan last year.

For more information, write to, or visit

News & Features

Terms & Conditions Privacy Policy About Us Contact Us
back to top
Facebook Twitter Instagram LinkedIn YouTube RSS
©2019 Photonics Media, 100 West St., Pittsfield, MA, 01201 USA,

Photonics Media, Laurin Publishing
x We deliver – right to your inbox. Subscribe FREE to our newsletters.
We use cookies to improve user experience and analyze our website traffic as stated in our Privacy Policy. By using this website, you agree to the use of cookies unless you have disabled them.